Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice

Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide

(2014) Hui-fang Zhou et al.   ACS Nano

Visualizing the atherosclerotic plaque: a chemical perspective

(2014) Ma Teresa Albelda et al.   CHEMICAL SOCIETY REVIEWS

Animal Models of Atherosclerosis

(2012) Godfrey S. Getz et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles

(2012) Hui-fang Zhou et al.   BIOMATERIALS

Therapeutic Angiogenesis for Treating Cardiovascular Diseases

(2012) Lorenzo Deveza et al.   Theranostics

p19ARFDeficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis

(2010) Herminia González-Navarro et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis

(2010) Mark E. Lobatto et al.   MOLECULAR PHARMACEUTICS

High-Relaxivity Gadolinium-Modified High-Density Lipoproteins as Magnetic Resonance Imaging Contrast Agents

(2009) Karen C. Briley-Saebo et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis

(2009) Michael J. Lipinski et al.   JACC-Cardiovascular Imaging

Imaging of atherosclerotic cardiovascular disease

(2008) Javier Sanz et al.   NATURE

Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in Atherosclerosis

(2008) Patrick M. Winter et al.   JACC-Cardiovascular Imaging